
AI Biomedical R&D Company
Asia's Premier Healthcare Industry Event - The Asian Summit on Healthcare (ASGH) will be held at the Hong Kong Convention and Exhibition Centre on May 26-27, aiming to explore international cooperation opportunities in the healthcare sector and showcase various business opportunities for investors and project owners.
GBB invites you to this grand event to explore how AI empowers the entire drug development process, from target/antibody discovery to early CMC in just 8 months. (Contact us at the end of the article to claim limited free exhibition tickets.)
150+ international exhibitors, 80+ authoritative leaders in-depth sharing:
· Heads of multinational pharmaceutical companies: Global executives from Germany's Merck Group and Mitsubishi Tanabe Pharma
· Experts from top hospitals in Hong Kong, Malaysia, France, the Netherlands, the UK, the US, and Brazil will share their practical experiences in innovating healthcare service models.
· Scholars in China and experts from top research institutions in the United States, South Korea, the United Kingdom, and other countries, with topics covering multiple fields such as biomedicine, AI healthcare, and innovation in traditional Chinese medicine.
· 360+ Investment Projects: Precise Matching of Capital and Innovation
· 260+ Cutting-edge Solutions: From Gene Therapy to Digital Healthcare, Addressing Industry Pain Points
· 30+ Start-up Roadshow: New Enterprises Within 8 Years Showcase Disruptive Technologies On-Site
· Day One Focus: Global Industry Trends, New Investment Tracks in China, Healthcare System Innovation, New Focus on Women's Health
· Breakthroughs on the Second Day: AI-Driven Healthcare, Healthy Aging, Modernization of Traditional Chinese Medicine, New Directions in Cancer Treatment
· Featured Exhibition Area: InnoHealth Showcase Highlights Cutting-edge Medical Technologies
· Field Trip: Visit to the GBB Biomedical Industry Base
· Customized Services: Healthcare Business Consulting, Global Networking Matchmaking
Dr. Hongjiang Miao, AI CTO of Great Bay Bio, will attend this conference with an intelligent drug development ecosystem.Show how GBB utilizes AI technology to empower the entire process of early drug discovery and bioprocess development, completing the journey from target/antibody drug discovery to early CMC work within 8 months. Particularly in the high-yield stable cell line construction phase, it has achieved a revolutionary change of obtaining monoclonal cells within 6 weeks and predicting product quality 4 weeks in advance.
▲6 Weeks for Monoclonal & 4 Weeks for Product Quality Prediction
The Asia Summit on Global Health (ASGH) is positioned as the premier health innovation and investment event in Asia. Jointly organized by the Hong Kong Special Administrative Region Government and the Hong Kong Trade Development Council, it serves as a one-stop platform that brings together all stakeholders – from policymakers to healthcare experts, renowned academics, influential business leaders, and key industry players, innovative startups, and investors from around the world – to exchange insights, explore opportunities, and collaborate in the diverse and dynamic healthcare sector.
Phone: 400 079 8808
18926497707 (Same number on WeChat)
Email: BD@greatbay-bio.com